SCHEMBL10146790

SCHEMBL10146790

C1=CC2Oc3c(cc(-c4ccc5c(-c6cccc(-c7ccc8ccccc8c7)c6)c6ccccc6c(-c6cccc(-c7ccc8ccccc8c7)c6)c5c4)c4ccccc34)C2C=C1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.34
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
GSTP1 P09211 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25497654 0.97 GPR84 (0.36) GPR84GSTP1
SCHEMBL12984702 0.95 GPR84 (0.34) GPR84GSTP1
SCHEMBL10147323 0.91
SCHEMBL12640765 0.89 GPR84 (0.34) GPR84HSD17B1HSD17B2
SCHEMBL10082723 0.87 HSD17B1 (0.35) GPR84HSD17B1HSD17B2GSTP1
SCHEMBL12640705 0.87 GPR84 (0.31) GPR84HSD17B1HSD17B2
SCHEMBL12640760 0.87 EDNRB (0.32) GPR84
SCHEMBL12984915 0.86 CA12 (0.33)
SCHEMBL10147322 0.86 EDNRB (0.31)
SCHEMBL179122 0.86 GPR84 (0.36) GPR84HSD17B1HSD17B2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120138914-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120138914-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME SOX18, ANXA1, ANXA11 GPR84 4597/4885HSD17B1 1538/4885HSD17B2 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.